River BioMedics-preview

Riverbiomedics

River BioMedics

Private

EnschedeHealthcare & Life Scienceshttps://riverbiomedics.com

Last Round

Seed

Jul 5, 2023

Total Funding Raised

$5.78M

Momentum Score

25 /100

Company Overview

River BioMedics is a biotechnology company that develops 3D human cardiac models for target validation and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cardiovascular drug discovery3D cardiac modelsHeart-on-a-Chiporgan-on-a-chiphiPSCinduced pluripotent stem cellsdrug discovery platformdrug target validationcompound screeningpreclinical servicescardiotoxicity screeningcardiac disease modelshuman-predictive models3D cell culturetissue engineeringsmall molecule drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

River BioMedics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

River BioMedics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 5, 2023
Grant	Jan 24, 2023
Seed	Jan 20, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Nicky Cooper

CEO

Executive Team

River BioMedics Investors

Notable investors and investment history

Investor	Rounds
European Innovation Council	Grant
Libertatis Ergo Holding	Seed
First Fund	Seed
KIKK Capital	Seed
BioGeneration Ventures	Seed
Oost NL	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 25, 2025
Presented latest work on 3D cardiac strips at MPS 2025.

View all signals

River BioMedics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

River BioMedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about River BioMedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEnschede

Employee Range14

Year Founded2020

Last FundingJul 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.